| Shasun Pharmaceuticals has reported a consolidated total income from operations of Rs 357.95 crore and a net profit of Rs 22.16 crore for the quarter ended Mar '15. | | For the quarter ended Mar 2014 the consolidated total income from operations was Rs 363.26 crore and net profit was Rs 10.40 crore. | | Shasun Pharma shares closed at 312.90 on April 29, 2015 (BSE) and has given 56.84% returns over the last 6 months and 161.62% over the last 12 months. |
|
| | Shasun Pharmaceuticals | | Consolidated Quarterly Results | -------- in Rs. Cr. -------- |
|
| Mar '15 | Dec '14 | | | Mar '14 | | Net Sales/Income from operations | 336.10 | 310.05 | | | 346.56 | | Other Operating Income | 21.85 | 14.95 | | | 16.70 | | Total Income From Operations | 357.95 | 325.00 | | | 363.26 | | EXPENDITURE | | | | | | | Consumption of Raw Materials | 181.12 | 177.62 | | | 177.12 | | Purchase of Traded Goods | 1.51 | 0.38 | | | 2.31 | | Increase/Decrease in Stocks | -3.21 | -15.23 | | | 11.63 | | Power & Fuel | -- | -- | | | -- | | Employees Cost | 59.72 | 59.56 | | | 55.22 | | Depreciation | 12.94 | 11.76 | | | 16.16 | | Excise Duty | -- | -- | | | -- | | Admin. And Selling Expenses | -- | -- | | | -- | | R & D Expenses | -- | -- | | | -- | | Provisions And Contingencies | -- | -- | | | -- | | Exp. Capitalised | -- | -- | | | -- | | Other Expenses | 78.25 | 69.99 | | | 76.71 | | P/L Before Other Inc., Int., Excpt. Items & Tax | 27.62 | 20.92 | | | 24.11 | | Other Income | 4.48 | 1.58 | | | 3.11 | | P/L Before Int., Excpt. Items & Tax | 32.10 | 22.50 | | | 27.22 | | Interest | 12.90 | 15.69 | | | 13.76 | | P/L Before Exceptional Items & Tax | 19.20 | 6.81 | | | 13.46 | | Exceptional Items | 7.85 | -- | | | -- | | P/L Before Tax | 27.05 | 6.81 | | | 13.46 | | Tax | 6.31 | -- | | | 3.03 | | P/L After Tax from Ordinary Activities | 20.74 | 6.81 | | | 10.43 | | Prior Year Adjustments | -- | -- | | | -- | | Extra Ordinary Items | -- | -- | | | -- | | Net Profit/(Loss) For the Period | 20.74 | 6.81 | | | 10.43 | | Minority Interest | -- | -- | | | -- | | Share Of P/L Of Associates | 1.42 | -0.67 | | | -0.03 | | Net P/L After M.I & Associates | 22.16 | 6.14 | | | 10.40 | | Equity Share Capital | 12.03 | 12.03 | | | 11.33 | | Reserves Excluding Revaluation Reserves | -- | -- | | | -- | | Equity Dividend Rate (%) | -- | -- | | | -- | | EPS Before Extra Ordinary | | | | | | | Basic EPS | 3.69 | 1.02 | | | 1.84 | | Diluted EPS | 3.58 | 0.99 | | | 1.84 | | EPS After Extra Ordinary | | | | | | | Basic EPS | 3.69 | 1.02 | | | 1.84 | | Diluted EPS | 3.58 | 0.99 | | | 1.84 | | Public Share Holding | | | | | | | No Of Shares (Crores) | 3.64 | 3.64 | | | 3.29 | | Share Holding (%) | 60.51 | 60.51 | | | 58.03 | | Promoters and Promoter Group Shareholding | | | | | | | a) Pledged/Encumbered | | | | | | | - Number of shares (Crores) | 0.31 | 0.29 | | | 0.67 | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | 13.13 | 12.29 | | | 28.14 | | - Per. of shares (as a % of the total Share Cap. of the company) | 5.19 | 4.85 | | | 11.81 | | b) Non-encumbered | | | | | | | - Number of shares (Crores) | 2.06 | 2.08 | | | 1.71 | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | 86.87 | 87.71 | | | 71.86 | | - Per. of shares (as a % of the total Share Cap. of the company) | 34.30 | 34.64 | | | 30.15 | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
